[DNLI] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
27-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -445.29%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 108,463 48,661 335,659 26,678 129,160 0 0 -
PBT -325,970 -291,156 71,959 -197,965 -36,240 -88,185 -86,652 24.69%
Tax 21 -575 823 -351 10,132 -3,082 0 -
NP -325,991 -290,581 71,136 -197,614 -36,240 -88,185 -86,652 24.69%
Tax Rate - - -1.14% - - - - -
Total Cost 434,454 339,242 264,523 224,292 165,400 88,185 86,652 30.80%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -300.56 -597.15 21.19 -740.74 -28.06 0.00 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -2.60 -2.39 0.65 -2.07 -0.39 -5.89 -13.49 -23.98%
EPS Diluted -2.60 -2.39 0.63 -2.07 -0.39 -5.89 -13.49 -23.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.